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Dysregulation or imbalance of their metabolic pathways may promote the development of retinal degen-
eration. The aim of this study was to identify the expression and regulation of key enzymes of the cera-
mide pathway in retinal pigment epithelial (RPE) cells. RT-PCR was used to screen the enzymes involved
in ceramide metabolism that are expressed in RPE. Over-expression of neutral sphingomyelinase-2
(SMPD3) or sphingosine kinase 1 (Sphk1) in ARPE-19 cells was achieved by transient transfection of
SMPD3 or Sphk1 cDNA subcloned into an expression vector. The number of apoptotic or proliferating
cells was determined using TUNEL and BrdU assays, respectively. Neutral sphingomyelinase-1, neutral
sphingomyelinase-2, acidic ceramidase, ceramide kinase, SphK1 and Sphk2 were expressed in both
ARPE-19 and early passage human fetal RPE (fRPE) cells, while alkaline ceramidase 2 was only expressed
in fRPE cells. Over-expression of SMPD3 decreased RPE cell proliferation and increased cell apoptosis. The
percentage of apoptotic cells increased proportionally with the amount of transfected SMPD3 DNA. Over-
expression of SphK1 promoted cell proliferation and protected ARPE-19 cells from ceramide-induced
apoptosis. The effect of C2 ceramide on induction of apoptosis was evaluated in polarized vs. non-polar-
ized RPE cultures; polarization of RPE was associated with much reduced apoptosis in response to cera-
mide. In conclusion, RPE cells possess the synthetic machinery for the production of ceramide,
sphingosine, ceramide-1-phosphate (C1P), and sphingosine-1-phosphate (S1P). Over-expression of
SMPD3 may increase cellular ceramide levels, leading to enhanced cell death and arrested cell prolifera-
tion. The selective induction of apoptosis in non-polarized RPE cultures by C2 ceramide suggests that
increased ceramide levels will preferentially affect non-polarized RPE, as are found in late age-related
macular degeneration lesions, and may spare the normal RPE monolayer. SphK1 over-expression
increased cellular S1P, which promoted cell proliferation and protected RPE from ceramide-induced
apoptosis. Understanding the relationship between the metabolism of sphingolipids and their effects
in RPE cell survival/death may help us to develop effective and efﬁcient therapies for retinal
degeneration.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Data from clinical and basic research have provided evidence
that apoptotic cell death plays a critical role in the pathogenesis
of age-related macular degeneration (AMD) and other retinal
degenerative diseases (Dorey, Wu, Ebenstein, Garsd, & Weiter,ll rights reserved.
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42 6688.1989; Sarks, 1976). However, the etiology and mechanism of
increased apoptosis in retinal pigment epithelial (RPE) cells in ret-
inal degeneration remain largely unknown. Such knowledge con-
cerning the mechanism of dysregulated apoptosis is critical
because it may lead to new approaches for the prevention and
treatment of these important disorders.
Ceramide is a central hub for sphingolipid metabolism; its
breakdown or modiﬁcation results in the production of several
sphingolipids such as sphingosine, sphingosine-1-phosphate
(S1P), and ceramide-1-phosphate (C1P) that, like ceramide itself,
can potentially serve as both structural and/or cell signaling mole-
cules (An, Yuhua Zheng, & Bleu, 2000; Cuvillier et al., 1996; Gulbins
& Li, 2006; Ogretmen & Hannun, 2004; Taha, Mullen, & Obeid,
644 D. Zhu et al. / Vision Research 50 (2010) 643–6512006; Zheng et al., 2006). In recent years, there has been an
upsurge of interest in unraveling the roles of ceramide in the path-
ophysiology of different human diseases including neurodegenera-
tive and retinal degenerative diseases. It is possible that targeted
manipulation of the ceramide metabolic pathway may prove to
be a novel strategy for treatment of neurodegenerative disease.
Furthermore, in addition to apoptosis, ceramide has been sug-
gested to play important roles in cell cycle arrest, inﬂammation,
and the eukaryotic stress response (Gulbins & Kolesnick, 2003;
Hannun & Luberto, 2000). Although ceramide can be generated
by de novo synthesis through ceramide synthase, for the majority
of cellular responses, it is generated from sphingomyelin by the
action of neutral or acid sphingomyelinase (Hannun, Luberto, &
Argraves, 2001).
Several sphingomyelinases (SMPDs) have been described in
eukaryotes and prokaryotes and they are distinguished by their
subcellular localization, pH optima, and requirement for metal ions
(Hofmann, Tomiuk, Wolff, & Stoffel, 2000; Marchesini & Hannun,
2004). To date, four SMPDs have been identiﬁed. The best charac-
terized of these enzymes is the acid sphingomyelinase (SMPD1)
that is predominantly located in lysosomes but also secreted in re-
sponse to different ligand–receptor interactions at the cell surface
(Schuchman, Suchi, Takahashi, Sandhoff, & Desnick, 1991). A total
of three neutral sphingomyelinases—SMPD2, SMPD3, and
SMPD4—are localized in different cellular compartments and ex-
pressed in different tissues (Hofmann et al., 2000; Tomiuk,
Hofmann, Nix, Zumbansen, & Stoffel, 1998). SMPD2 is localized
in the endoplasmic reticulum (ER) and expressed in all cell types
(Zumbansen & Stoffel, 2002). SMPD3 is expressed at highest levels
in the brain, is activated by tumor necrosis factor a (TNFa), and
contributes to TNFa-induced apoptosis in cultured cells (Clarke,
Truong, & Hannun, 2007). SMPD3-null mice have signiﬁcant devel-
opmental defects, including dwarﬁsm and delayed puberty (Stoffel,
Jenke, Block, Zumbansen, & Koebke, 2005). Stable over-expression
of SMPD3 in MCF7 cells results in a markedly decreased growth
rate at the late exponential phase, suggesting that SMPD3 is in-
volved in the regulation of the cell cycle (Marchesini, Luberto, &
Hannun, 2003). SMPD4 is localized in the ER as well as in the Golgi,
and has been shown to be activated in response to TNFa, although
its physiological role has yet to be deﬁned (Krut, Wiegmann,
Kashkar, Yazdanpanah, & Kronke, 2006).
SphKs are critical enzymes that regulate the cellular levels of
S1P and thus ultimately control cell fate. SphKs are ubiquitously
expressed and exist in two subtypes, SphK1 and SphK2 (Alemany
et al., 2007; Bryan, Kordula, Spiegel, & Milstien, 2008). SphK1 has
major roles in cell proliferation and migration and is expressed
in different tumors (Alemany et al., 2007). Recent studies implicate
endogenous SphK1 as an important survival enzyme. Knocking
down the Sphk1 expression by siRNA gene silencing could cause
cell cycle arrest and induce apoptosis by the activation of caspases
and the oligomerization of Bax on the mitochondrial membrane
(Taha et al., 2006). SphK2, on the other hand, has different proper-
ties and subcellular locations from Sphk1. Although Sphk1 and
Sphk2 are able to complement each other for some key functions,
Sphk2 has distinct biological functions, and even has opposing
roles in the regulation of cell fate. It has been reported that Sphk2
has pro-apoptotic function and the over-expression of SphK2 in
various cell types blocks DNA synthesis (Igarashi et al., 2003; Liu
et al., 2003).
Our laboratory recently established that oxidative stress in-
duced by exogenous ceramide leads to apoptosis in human RPE
cells and that this effect could be partially prevented by growth
factors and antioxidants (Kannan, Jin, Gamulescu, & Hinton,
2004; Sreekumar, Ding, Ryan, Kannan, & Hinton, 2009). However,
the precise mechanisms of the cellular action of ceramide and
the enzymes that are involved in the sphingolipid pathway inRPE have not been fully explored. Expression and regulation of
sphingolipid metabolizing enzymes in the RPE has not been hith-
erto studied. Because neutral SMPD3 and SphK1 were highly ex-
pressed in RPE cells and have opposing functions for evaluating
their roles in mediating cell fate, we focused on the regulation
and function of SMPD3 and SphK1 in RPE. Our data shows that
over-expression of SMPD3 induced RPE cell death and inhibited
cell proliferation, whereas over-expression of SphK1 induced cell
proliferation and protected RPE cells from cell death after C2 cera-
mide exposure.
2. Methods
2.1. Cell culture
A. ARPE-19 cell culture: ARPE-19 cells were obtained from
American Type Culture Collection (Manassas, VA) and were
used between passages 22 and 25. ARPE-19 cells were cul-
tured in DMEM/F12 (1:1) medium supplemented with
100 U/mL penicillin–streptomycin, 2 mM L-glutamine, and
10% FBS.
B. Human fetal RPE (fRPE) cell culture: Human fRPE were iso-
lated from 18 to 20 week gestation fetal eyes (Advanced
Bioscience Resources, Inc. Alameda, CA) and digested with
trypsin to single cells (Sonoda et al., 2009). The fRPE
cells were then cultured in DMEM supplemented with
100 U/mL penicillin–streptomycin, 2 mM L-glutamine, and
10% FBS. The fRPE cells used for experiments at passage
3 or 4.
C. Polarized fRPE cell culture: Passage 1 human fRPE cells
(2  105 for each well) were seeded on ﬁbronectin-coated
transwell membranes, and cultured in RPE medium with
1% FBS as previously described (Sonoda et al., 2009). The
formation of tight junctions among the cells was deter-
mined by measuring the trans-epithelial resistance (TER)
with an EVOM epithelial tissue voltohmmeter. Polarized
fRPE cells with a resistance of >170X cm2 were used in
our study.2.2. Cell treatment
A. GW4869 treatment: After transient transfection for 24 h, the
SMPD3 overexpressed or vector only control ARPE-19 cells
were treated with 20 lM GW4869, a speciﬁc neutral sphin-
gomyelinase inhibitor (Luberto et al., 2002), for 45 min, then
changed to fresh, serum-free medium and cultured for
another 16 h.
B. C2 ceramide treatment: After transient transfection for 24 h,
the SphK1 overexpressed or vector only control ARPE-19
cells were challenged with 25 lM C2 ceramide in 1% FBS
medium for 16 h.2.3. Subcloning and transfection of neutral sphingomyelinase and
sphingosine kinase-1
SMPD3 and SphK1 cDNA were ampliﬁed by RT-PCR and sub-
cloned into a pcDNA 3.1 mammalian cell expression vector (Invit-
rogen, Carlsbad, CA). SMPD3 or SphK1 cDNA containing plasmid or
pcDNA 3.1 vector only were transfected at different concentrations
(0.1–1 lg) into ARPE-19 cells by using Fugene 6 transfection re-
agent (Roche, IN). In representative experiments, ARPE-19 cells
were transfected with pEGFP-N1 plasmid (BD Biosciences, Clon-
tech) and the efﬁciency of transfection was recorded by counting
the number of GFP positive cells under a ﬂuorescent microscope.
The transfection efﬁciency was typically 50% or higher in all
experiments.
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Total RNA was extracted from SMPD3, SphK1, pcDNA3.1 vector
only transfected ARPE-19 cells using TRIzol reagent (Invitrogen,
Carlsbad, CA) and quantiﬁed with a spectrophotometer. The ﬁrst
strand cDNAwas synthesized from 1 lg total RNAwith a cDNA syn-
thesis kit as per manufacturer’s protocol (Promega, Madison, WI).
The detection of the ceramide metabolic pathway enzymes was
achieved by PCR ampliﬁcation using speciﬁc primers with a PCR
kit (Qiagen, Valencia, CA). GAPDH was used as an internal loading
control. Speciﬁcity of the reaction was veriﬁed with no-template
negative control. The speciﬁc primer pairs used in screening en-
zymes of the ceramide pathways by RT-PCR are listed in Table 1.
2.5. Western blot analysis
SphK1 overexpressing and control ARPE-19 cells were homog-
enized in RIPA buffer (50 mM Tris–HCl, pH8.0, 150 mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS) with 1X
protease inhibitor cocktail (Sigma). Equal amounts of protein
from each sample (10 lg/well) underwent electrophoresis on
10% polyacrylamide gels and were electrically transferred to a
PVDF membrane (Millipore Corp, Jeffery, NH). A rabbit anti-SphK1
polyclonal antibody (1:1000 dilution; Cayman Chemical, Ann Ar-
bor, MI) was used to detect the expression levels of the SphK1
protein. Quantiﬁcation of the SphK1 protein was made by mea-
suring band intensity and area using Scion software (NIH) and
normalized to GAPDH.
2.6. TUNEL assayA. Quantitative measure of apoptotic cells: The cells were col-
lected by trypsinization and ﬁxed with 2% paraformaldehyde
in PBS pH 7.4. Apoptotic cells were labeled using the termi-
nal deoxynucleotidyl transferase (TdT)-mediated dUTP-ﬂuo-
rescein nick end-labeling (TUNEL) cell death detection kit
(Roche, IN) according to the manufacturer’s instructions,
and quantitated by ﬂow cytometric analysis.
B. In situ staining of apoptotic cells: Polarized and non-polar-
ized conﬂuent fRPE cells were treated with 25 lM C2 cera-
mide for 24 h in 1% serum containing culture medium. TheTable 1
Primer pairs used to amplify enzymes involved in ceramide metabolic pathway.
Name of genes Forward (F)/Reverse (R)
Acid sphingomyelinase (SMPD1) F
R
Neutral sphingomyelinase 1 (SMPD2) F
R
Neutral sphingomyelinase 2 (SMPD3) F
R
Acid ceramidase (ASAH1) F
R
Alkaline ceramidase 1 (ACER1) F
R
Alkaline ceramidase 2 (ACER2) F
R
Neutral ceramidase (ASAH2) F
R
Ceramide kinase (CerK) F
R
Ceramide kinase like (CERKL) F
R
Sphingosine kinase 1 (SphK1) F
R
Sphingosine kinase 2 (SphK2) F
R
GAPDH F
Rtreated cells were then ﬁxed in 4% paraformaldehyde, per-
meabilized with 0.1% Triton X-100 and 0.1% sodium citrate,
and incubated with TdT enzyme mixture using a cell death
detection kit (Roche, IN). The number of TUNEL positive cells
were counted under a ﬂuorescent microscope and presented
as the percentage of dead cells.2.7. BrdU incorporation assay
After being transiently transfected with varying quantities of
SMPD3 cDNA, SphK1 cDNA or vector only for 24 h, the transfected
ARPE-19 cells were trypsinized, re-seeded on chamber slides or 96-
well plates and continued to be cultured for 16 h. The cells were
then treated with BrdU (10 lM) for 6 h. The BrdU incorporation
rates of control and transfected cells were measured with the BrdU
Incorporation Assay Kit (Roche, IN) by in situ BrdU immunostain-
ing, or by cell proliferation ELISA according to the manufacturer’s
instructions.
2.8. Statistical analysis
Data presented represent mean + SD. ANOVA was used to iden-
tify the global differences on data collected from TUNEL and BrdU
incorporation assays. Multiple pairwise comparisons with Tukey
adjustment were performed to test the differences between the ef-
fects of inhibitor treated and non-treated SMPD3 overexpressing
cells or C2 ceramide treated and non-treated Sphk1 overexpressing
cells. All p-values reported were 2-sided, and p < 0.05 was consid-
ered statistically signiﬁcant.3. Results
3.1. Expression of sphingolipid metabolizing enzymes in ARPE-19 and
fRPE cells
Understanding the expression of the spectrum and dominant
isoforms of the sphingolipid metabolic pathway enzymes in
RPE cells can help us determine which enzymes participate in
the sphingolipid metabolism in RPE cells. We screened the sphin-
golipid metabolic pathway enzymes with RT-PCR ampliﬁcation,Length of ampliﬁed cDNA Primer sequences
750 bp 50-C AGCCGACTAC AGAGAAGGG
50-GC AGGTC AGTGAGGAAGAGG
553 bp 50-C ATGGTGACTGGTTC AGTGG
50-TAGAGCTGGGGTTCTGCTGT
526 bp 50-ACCAACCCTCACTTCACAGG
50-GGCTGCTCTCTGTACCTTGG
433 bp 50-AGTCTGGGGAAGGTTGTGTG
50-CCGCGAGTCTTAGTCTTTGG
498 bp 50-TGCTATTTCCCCTCCTTCCT
50-TAGTCAAGAGGCTGGCAGGT
338 bp 50-AGGTTCAAGGTGGTGGTCAG
50-GAGGCAGCATCAAAGTAGGC
402 bp 50-TGCAGATCAACAGAAGTCCG
50-TAGCAATGCACATGCTAGGC
488 bp 50-GAGAAGCTGACGTCCAGACC
50-GACACGGAGTAGCGAAGGAG
453 bp 50-TAGCGAAGTAGCCCATGCTT
50-TCAGATTTGGGAGATCCCTG
532 bp 50-ATCTCCTTCACGCTGATGCT
50-CAGGTGTCTTGGAACCCACT
470 bp 50-CGCTGTTTCTCCTTCCTGTC
50-GAGTGTAGAGCTGCCTTGGG
420 bp 50-GTCAGTGGTGGACCTGACCT
50-AGGGGTCT AC ATGGC AACTG
Fig. 2. Over-expression of SMPD3 and SphK1 in ARPE-19 cells conﬁrmed by RT-PCR
and western blot assays. (A) RT-PCR: Total RNA was extracted from ARPE-19 cells
transiently transfected with pcDNA3.1-SMPD3, pcDNA3.1-SphK1 or pcDNA3.1
vector only and reversely transcripted to cDNA. The templates were ampliﬁed
with a PCR kit and the result showed that ARPE-19 cells transfected with SMPD3 or
SphK1 expression vector expressed higher level of SMPD3 or SphK1 transcripts than
vector only transfected cells. (B) Western blot analysis: The protein from ARPE-19
cells transiently transfected with pcDNA3.1-SphK1 or pcDNA3.1 vector only was
electrophoresed using a 10% polyacrylamide gel with 10 lg of cell lysate loaded in
each lane and was transferred to a PVDF membrane. Densitometric analysis of
SphK1 immunoreactive bands after normalization with GAPDH, shows 3.6 and 4.1-
fold increase in SphK1 expression in 2 independent experiments using SphK1
transfected ARPE-19 cells.
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sphingomyelinase 2 (SMPD3), acidic ceramidase (ASAH1), cera-
mide kinase (CERK) and sphingosine kinases (SphKs) were ex-
pressed in both ARPE-19 and human fRPE cells, while alkaline
ceramidase 2 (ACER2) was only expressed in fRPE (Fig. 1). Acidic
sphingomyelinase (SMPD1), alkaline ceramidase 1 (ACER1), neu-
tral ceramidase (ASAH2) and ceramide kinase-like (CERKL) were
not detectable in the RPE cells with RT-PCR.
3.2. Over-expression of SMPD3 renders ARPE-19 cells more susceptible
to apoptosis
Increased ceramide levels have been shown to induce cell cycle
arrest, apoptosis and cell differentiation (Hannun & Luberto, 2000).
In order to assess whether the effects of changes in cellular sphin-
golipid content would modulate the RPE cell fate, we increased the
expression of SMPD3 or SphK1 by transient transfection of SMPD3
and Sphk1 expression vectors into ARPE-19 cells and measured the
changes in the rate of RPE cell death and growth. The over-expres-
sion of transcripts for SMPD3 and Sphk1, and protein for Sphk1 in
ARPE-19 cells was conﬁrmed by RT-PCR and western blot, respec-
tively (Fig. 2A and B).
SMPD3-overexpressing ARPE-19 cells exhibited signiﬁcantly in-
creased apoptosis with serum starvation as compared to vector
only controls (46% vs. 4%, respectively, p < 0.01, Fig. 3). ARPE-19
cells transfected with increasing amounts of SMPD3 DNA showed
a dose-dependent increase in apoptotic cells as evident by TUNEL
assay. To conﬁrm that the apoptosis was truly induced by the in-
creased SMPD3 expression in ARPE-19 cells, we introduced
GW4869, a neutral sphingomyelinase inhibitor, into SMPD3 over-
expressing cells. The apoptotic RPE cells were signiﬁcantly reduced
by pre-treatment with 20 lM GW4869 in all SMPD3 overexpress-
ing cells transfected with different DNA concentrations (p < 0.05)
(Fig. 4).
3.3. SphK1-overexpressing cells are resistant to apoptosis after
oxidative insult
Sphk1 is an important enzyme for the formation of S1P, which
functions as an extracellular or intracellular messenger that mod-
ulates cell fates, including the suppression of apoptosis and the in-
crease of cell proliferation (An et al., 2000). To verify the function of
Sphk1 in RPE cells, we overexpressed Sphk1 in ARPE-19 cells by the
transient transfection of Sphk1 expression vector. The percentage
of apoptotic cells in the SphK1-overexpressing cells was similar
to the vector only controls. We then challenged the SphK1-over-Fig. 1. Expression of sphingolipid enzymes by ARPE-19 and early passage human
fetal RPE (fRPE) cells as determined by RT-PCR. Messenger RNA from human ARPE-
19 and fRPE cells was reverse-transcribed and ampliﬁed by speciﬁc primers for
sphingolipid metabolic pathway enzymes (see Table 1). SMPD2, SMPD3, ASAH1,
CERK and Sphks are expressed in both ARPE-19 and fRPE cells. ACER2 is only
expressed in fRPE cells. Lane 1, DNA marker; 2, acid sphingomyelinase (SMPD1); 3,
neutral sphingomyelinase 1(SMPD2); 4, neutral sphingomyelinase 2 (SMPD3); 5,
acid ceramidase (ASAH1); 6, alkaline ceramidase 1 (ACER1); 7, alkaline ceramidase
2 (ACER2); 8, neutral ceramidase (ASAH2); 9, ceramide kinase (CERK); 10, ceramide
kinase like (CERKL); 11, sphingosine kinase 1 (SphK1); 12, sphingosine kinase 2
(SphK2); 13, GAPDH; 14, negative control.expressing cells with 25 lM C2 ceramide and measured the
number of apoptotic cells by ﬂow cytometric analysis of TUNEL-
stained cells. About 36% of cells underwent apoptosis in the vector
only control group with C2 ceramide-induced oxidative stress,
while a dose-dependent decrease in cell death was observed in
SphK1 transfected cells (Fig. 5). Only 10% cell death was observed
in cells transfected with 0.5 lg SphK1 DNA (p < 0.01), suggesting
its protective role in ceramide-induced oxidative stress in ARPE-
19 cells.3.4. SMPD3 and SphK1 have an opposing effect on cell proliferation in
ARPE-19 cells
To understand whether SMPD3 and Sphk1 have opposing ef-
fects on RPE proliferation, we overexpressed SMPD3 or Sphk1 in
ARPE-19 cells by transient transfection with different amounts of
SMPD3 or Sphk1 expression plasmids (0.1–1 lg) and treated these
overexpressed cells with BrdU for 6 h. The BrdU incorporation re-
sult showed signiﬁcantly decreased BrdU uptake by SMPD3-over-
expressing cells even at the lowest amount of transfected DNA
(0.1 lg) (p < 0.05) compared to the vector only control cells
(Fig. 6A), while SphK1 over-expression, on the other hand, signiﬁ-
cantly increased BrdU incorporation in a dose-dependent manner
in RPE cells. This indicates that SMPD3 inhibits RPE cell prolifera-
tion through hydrolysis of sphingomyelin to produce ceramide,
and Sphk1 has the opposite function to increase RPE cell prolifera-
tion, possibly through phosphorylating sphingosine to form S1P
(Fig. 6A and B).
Fig. 3. Augmentation and suppression of cell death in SMPD3 overexpressing and SphK1 overexpressing RPE by TUNEL. ARPE-19 cells were transiently transfected with
pcDNA 3.1-SMPD3 or pcDNA 3.1-SphK1 for 24 h, afterward the cells were continuously cultured in serum-free medium for 16 h. The cells were ﬁxed and incubated with TdT
enzyme with ﬂuorescein labeled dUTP. The results show that there are more TUNEL positive cells (apoptotic cells) in SMPD3 transfected than vector only transfected ARPE-19
cells, and no signiﬁcant difference between TUNEL positive cells in Sphk1 and vector only transfected cells. (A) Cells transfected with pcDNA3.1 vector only as a control; (B)
cells transfected with pcDNA 3.1-SMPD3; and (C) cells transfected with pcDNA 3.1-SphK1. The percentage of TUNEL positive cells in each group (three independent
experiments), is shown as a bar graph below (p < 0.01). Bar = 40 lM.
Fig. 4. Over-expression of SMPD3 enhances RPE cell death. ARPE-19 cells were transiently transfected with increasing amounts of pcDNA 3.1-SMPD3 plasmid. The control
and transfected cells were cultured in serum-free medium for 16 h. In SMPD3 inhibition experiments, control and transfected cells were treated with 20 lM GW4869, a
neutral sphingomyelinase inhibitor for 45 min, and then changed into serum-free medium and cultured for 16 h. The cells were labeled by ﬂuorescent TUNEL assay. The
apoptotic cells were measured by ﬂow cytometry. Over-expression of SMPD3 increased the number of apoptotic cells in a dose-dependent manner, while incubation with
GW4869 reduced SMPD3-induced ARPE-19 cell apoptosis. Mean values from three independent experiments are presented. Apoptosis was signiﬁcantly increased in all
groups of SMPD3 transfected cells compared to vector only control, and also signiﬁcantly increased among the groups with ascending DNA concentrations (p < 0.05, ANOVA).
All values for the GW4869 group were signiﬁcantly lower than the corresponding SMPD3-DNA values (p < 0.05, Student’s t test).
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ceramide treatment
To examine whether the upregulation of cellular ceramide
might induce cell death in the normal RPE monolayer in vivo, we
used highly polarized RPE cells, grown on transwell membranes
to mimic the in vivo situation, and non-polarized conﬂuent RPEcells, grown on chamber slides as a representation of activated
RPE such as those found in AMD lesions, or in epiretinal mem-
branes such as those found in proliferative vitreoretinopathy
(PVR) (Campochiaro, Kaden, Vidaurri-Leal, & Glaser, 1985; Hinton,
He, & Lopez, 1998). Polarity of RPE monolayer was conﬁrmed by
measurement of trans-epithelial resistance (TER); mean resistance
measured 170 ± 9.5X cm2 and did not change signiﬁcantly after
Fig. 5. SphK1 protects ARPE-19 cells from ceramide-induced cell death. ARPE-19
cells were transiently transfected with increasing amounts of pcDNA 3.1-SphK1
plasmid for 24 h and challenged with C2-ceramide (25 lM) for 16 h in 1% serum.
The percentage of apoptotic cells was measured by TUNEL stain followed by ﬂow
cytometry. The result shows that SphK1 transfection signiﬁcantly decreased the
number of apoptotic cells upon challenge with ceramide in a dose-dependent
manner compared to vector only control cells (p < 0.05; p < 0.01, ANOVA). Mean
data from at least three independent experiments is presented.
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non-polarized RPE cells subjected to 24 h ceramide treatment,
while less than 2% cell death was observed in polarized cultures,
indicating that the normal RPE monolayer in vivo may have more
resistance to ceramide challenge than activated RPE such as those
found in AMD lesions or in PVR (p < 0.001) (Fig. 7A and B).Fig. 6. BrdU incorporation to assay cell proliferation. (A) ARPE-19 cells were transiently
24 h, and then treated with BrdU (10 lM) for 6 h. The BrdU incorporation rate by ARPE-
ﬁgure shows that over-expression of SphK1 increased BrdU incorporation, while over-exp
The signiﬁcant increases or decreases of BrdU incorporation by Sphk1 or SMPD3, resp
transfected cells were immunostained with anti-BrdU antibody. The result shows that th
and fewer BrdU positive cells in SMPD3 transfected cells than vector only control cells. A r4. Discussion
Apoptosis, or programmed cell death, plays a critical role in the
pathogenesis of many blinding diseases, including the late stages
of AMD (Beatty, Koh, Phil, Henson, & Boulton, 2000; Hinton et al.,
1998). Understanding the causes and mechanisms of such degen-
erative disorders will help us to devise new approaches to prevent
and treat these diseases. The association between intracellular cer-
amide production and oxidative injury has been well established.
Ceramide plays a critical role in apoptosis, proliferation, cellular
senescence, and gene regulation through modulation of a variety
of protein kinases and phosphatases and activation of transcription
factors such as NFkappaB (Ruvolo, 2003). The close link between
reactive oxygen species (ROS) generation, sphingolipid metabolism
and ceramide production has been investigated in several cell
types that include RPE, retinal pericytes and photoreceptors (Barak,
Morse, & Goldkorn, 2001; Cacicedo, Benjachareowong, Chou,
Ruderman, & Ido, 2005; Denis et al., 2002; Kannan et al., 2004;
Mansat-deMas et al., 1999). It was reported that ceramide-induced
oxidative stress by increasing ROS generation or by inhibiting the
ROS scavenger glutathione in lung epithelial cells (Laventriadou
et al., 2001). Any dysregulation or imbalance of ceramide or its
metabolic products could play a role in the development of apop-
tosis and disease states such as retinal degeneration (Acharya et al.,
2003; Obeid, Linardic, Karolak, & Hannun, 1993; Tuson, Marfany, &
Gonzalez-Duarte, 2004).
Ceramide and its metabolic products are generated by a series
of enzymatic reactions. The multiple routes of generation and re-
moval of ceramide and its derivates exist in a variety of cell types
(Gulbins & Li, 2006). To better understand the ceramide metabolic
pathway in RPE cells, we screened the expression of ceramide met-
abolic pathway enzymes and found that SMPD2, SMPD3, ASAH1,
CERK and Sphks were expressed in both ARPE-19 and human fRPE
cells indicating that some, but not all, ceramide metabolic path-
ways, exist in RPE. Our data suggested that RPE cells may utilizetransfected with increasing amounts of pcDNA 3.1-SMPD3 or pcDNA 3.1-SphK1 for
19 cells were detected by cell proliferation ELISA measured with ELISA Reader. The
ression of SMPD3 decreased BrdU incorporation compared with vector only control.
ectively, were at DNA concentration 0.5 lg and above (p < 0.05, ANOVA). (B) The
ere are more BrdU positive cells in SphK1 transfected cells than vector only control,
epresentative image from three independent experiments is presented. Bar = 40 lM.
Fig. 7. Exogenously added C2 ceramide induces greater apoptosis in non-polarized RPE cells compared to polarized RPE. (A) Polarized fRPE and conﬂuent fRPE were incubated
with 25 lM C2 ceramide in 1% serum containing medium. Apoptotic cells (red) were determined by ﬂuorescent TUNEL assay as described in the methods. Cell nuclei (blue)
were labeled with DAPI. Bar = 40 lM. (B) Semiquantitative measurement of TUNEL positive cells. Apoptosis was signiﬁcantly higher in non-polarized than in polarized RPE
cells subjected to C2 ceramide treatment (p < 0.01, Student’s t test). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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ation, ASAH1 to cleave ceramide to form sphingosine, or CERK to
phosphorylate ceramide to become C1P, and Sphks, mainly Sphk1,
to phosphorylate sphingosine to form S1P. Thus, RPE cells can gen-
erate ceramide and sphingosine, which have been demonstrated to
induce cell cycle arrest and apoptosis, and can also generate C1P
and S1P, which act as antagonists of ceramide and sphingosine to
promote cell proliferation and protect cells from a variety of
insults.
To establish the association between altered metabolic path-
ways of major sphingolipids and dysfunction of retinal cells, we
artiﬁcially manipulated the sphingolipid metabolic pathways by
over-expression of speciﬁc enzymes in the ceramide pathway,
and examined the causal inﬂuence of these modulations on the
morphology, cell death and survival of RPE in vitro. In this study,
we evaluated the induction of apoptosis and cell proliferation after
over-expression of SMPD3 or SphK1 in ARPE-19 cells. Our data are
consistent with the view that these ceramide metabolic enzymes
have opposing functions in regard to cell survival and proliferation;
SMPD3 is pro-apoptotic and anti-proliferative, while SphK1 pro-
motes cell proliferation, with no signiﬁcant change in % apoptosis
when compared to vector only control cells. Since these experi-
ments do not address rescue of individual cells, the overall effect
of SphK1 over-expression may be due to shifting the balance to-
ward cell proliferation.
In recent years increased attention has been given to neutral
sphingomyelinase for its multiple roles in modulating an array of
cellular processes such as cell cycle arrest, cell differentiation and
apoptosis through the generation of ceramide (Hannun & Luberto,
2000). Our data revealed that SMPD3 overexpressing cells are
highly susceptible to apoptosis under serum deprivation condi-tions, suggesting that ceramide accumulation in cells may be
inducing cell death. In support of this view, overexpressing SMPD3
in a human breast cancer cell line, MCF-7, increased cell death in-
duced by the anti-cancer drug daunorubicin, and overexpressing
SMPD3 in a human oligodendroglioma derived cell line, HOC, also
enhanced cell death induced by staurosporine (Goswami et al.,
2005; Ito et al., 2009). Under our experimental conditions, we
found a 25% decrease in cell proliferation rate in SMPD3-over-
expressing vs. vector only control ARPE-19 cells, which is similar
to the ﬁndings in SMPD3-overexpressing MCF7 cells, although dif-
ferent assays were used in the two studies (Marchesini et al.,
2003). The biological signiﬁcance of the role of SMPD3 on the inhi-
bition of cell proliferation needs to be established by further work.
To conﬁrm that the cell death and cell growth arrest were in-
duced by increased SMPD3 expression that, in turn, resulted in in-
creased cellular ceramide level, we inhibited SMPD3 by incubating
ARPE-19 cells with GW4869 and found a signiﬁcant increase in cell
proliferation associated with a signiﬁcant decrease in cell death,
which could be attributed to a decrease in ceramide levels. How-
ever, GW4869 could not completely prevent the cell death induced
by over-expression of SMPD3. The reason for this incomplete, but
signiﬁcant, inhibition of cell death by GW4869 is most likely be-
cause, although GW4869 can completely inhibit cellular neutral
sphingomyelinase activity in vitro, it only partially prevents the re-
lease of cytochrome c from mitochondria (Luberto et al., 2002). It
has been demonstrated that ceramide exerts a direct effect on
mitochondria to produce reaction oxygen species (ROS), eventually
leading to mitochondrial dysfunction and the release of cyto-
chrome c and Bax to induce apoptosis (Garcia-Ruiz, Colell, Mari,
Morales, & Fernandez-Checa, 1997; Quillet-Mary et al., 1997). It
is unclear why GW4869 only partially blocks cytochrome c release
650 D. Zhu et al. / Vision Research 50 (2010) 643–651from mitochondria. It is possible that the mitochondria may have
already been partially damaged by the high cellular ceramide lev-
els resulting from SMPD3 action before addition of the inhibitor.
Sphingosine kinases (SphKs) are key enzymes regulating the
production of S1P, which determines important cellular responses,
including cell growth and apoptosis (Hait, Oskeritzian, Paugh,
Milstien, & Spiegel, 2006). Our data shows that the over-expression
of SphK1 renders cells more resistant to ceramide-induced cell
death, with 45% less apoptotic cells observed in SphK1-over-
expressing cells that those in vector only control cells. This may
arise from a decline in cellular ceramide levels that could trigger
apoptotic signaling. A number of studies in various cell types re-
vealed that the over-expression of SphK1 and increased S1P pro-
duction promote cell growth, enhance the G1/S transition and
increase cells in S-phase (Olivera et al., 1999). Furthermore, siRNA
mediated gene silencing of SphK1markedly decreased cell prolifer-
ation in glioblastoma cells and increased cell death (Van Brocklyn
et al., 2005). The precise mechanisms of SphK1 action in RPE re-
main to be elucidated.
Our previous work had suggested indirectly that increased cer-
amide levels might differentially affect polarized RPE, as are found
in the normal RPE monolayer, as opposed to non-polarized RPE, as
are found in late AMD lesions (Sreekumar et al., 2008; Vogt et al.,
2009). To directly test this hypothesis, we evaluated the effect of
C2 ceramide on polarized human RPE cultures in comparison to
non-polarized cultures and indeed, found that polarized RPE cul-
tures were much more resistant to the apoptotic effects of C2 cer-
amide. This suggests that increased ceramide levels may have
more profound effects at the site of late AMD lesions where it
may promote the progression of the disease by increasing
apoptosis.
In summary, we report for the ﬁrst time the pattern of expres-
sion of several ceramide metabolizing enzymes in ARPE-19 cells
and early passage fRPE. The role of SMPD3 and SphK1 in cell pro-
liferation and cell death was also studied. SMPD3-overexpressing
cells were found to be highly susceptible to cell death even without
oxidant injury and exhibited a decrease in cell proliferation. On the
other hand, SphK1 was antiapoptotic and protected ARPE cells
from ceramide-induced oxidative injury. Furthermore, the prolifer-
ation rate of SphK1-overexpressing cells was signiﬁcantly higher
than that of control cells. These ﬁndings are likely to have some
clinical applications. For example, it was shown that oxidized
low density lipoproteins (oxLDL) accumulate in AMD lesions
in vivo, and induce signiﬁcant increases of sphingomyelin, cera-
mides and cholesteryl esters in ARPE-19 cells in vitro (Yamada
et al., 2008). Further, neutral ceramidase was shown to rescue pho-
toreceptor degeneration in Drosophila, while the inhibition of cer-
amide synthesis prevented paraquat-induced cell death in rat
photoreceptor cultures (Acharya et al., 2003; German, Miranda,
Abrahan, & Rotstein, 2006). Recently, anti-sphingosine-1-phos-
phate monoclonal antibodies have been shown to inhibit retinal
and choroidal angiogenesis in mice (Caballero et al., 2009; Xie
et al., 2009). Thus, our present work in RPE, in conjunction with
the above mentioned function of ceramide pathway in photorecep-
tor cell death and rescue, points to a potential therapeutic use of
regulators of ceramide metabolism in treatment of retinal degener-
ative diseases.
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